Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,314 | -4,551 | -3,114 | -4,925 | -4,604 |
| Depreciation Amortization | 114 | 77 | 40 | 186 | 161 |
| Accounts receivable | 233 | 124 | 56 | 19 | 151 |
| Other Working Capital | 287 | 794 | 730 | -337 | -356 |
| Other Operating Activity | 474 | 247 | 622 | -2,635 | -1,386 |
| Operating Cash Flow | $-5,207 | $-3,310 | $-1,666 | $-7,692 | $-6,034 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 5,000 | 5,000 |
| PPE Investments | N/A | N/A | N/A | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $4,998 | $5,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 414 | -196 | N/A | 350 | 350 |
| Common Stock Issued | 6,553 | N/A | N/A | 1,828 | N/A |
| Other Financing Activity | -241 | 0 | -117 | -363 | -248 |
| Financing Cash Flow | $6,726 | $-196 | $-117 | $1,814 | $102 |
| Exchange Rate Effect | -7 | 0 | 1 | -8 | -5 |
| Beginning Cash Position | 5,787 | 5,787 | 5,787 | 6,675 | 6,675 |
| End Cash Position | 7,300 | 2,281 | 4,005 | 5,787 | 5,737 |
| Net Cash Flow | $1,513 | $-3,506 | $-1,782 | $-888 | $-938 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,207 | -3,310 | -1,666 | -7,692 | -6,034 |
| Capital Expenditure | N/A | N/A | N/A | -2 | N/A |
| Free Cash Flow | -5,207 | -3,310 | -1,666 | -7,694 | -6,034 |